Ep300 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
EP300 (E1A-associated protein p300) encodes a transcriptional coactivator and histone acetyltransferase (HAT) that plays crucial roles in gene expression, chromatin remodeling, and cellular differentiation. It is essential for learning, memory, and neuronal plasticity. [@yamakawa2017]
Overview
The EP300 gene encodes the p300 protein, a member of the p300/CBP (CREB-binding protein) family of transcriptional coactivators. p300 functions as a molecular scaffold, bridging transcription factors with the basal transcription machinery and modifying chromatin through its histone acetyltransferase activity. Mutations in EP300 are associated with Rubinstein-Taybi syndrome and contribute to neurodegeneration. [@chatterjee2021]
Gene Information
Molecular Function
p300/CBP are master regulators of transcription through:
Histone Acetylation: Acetylates histone H3/H4, loosening chromatin for transcription
Transcriptional Coactivation: Interacts with >400 transcription factors
Chromatin Remodeling: Recruits SWI/SNF complexes
p53 Acetylation: Stabilizes p53 for tumor suppression
CREB-mediated Transcription: Essential for cAMP-responsive gene expression
Key neuronal functions:
Synaptic plasticity and [LTP](/mechanisms/long-term-potentiation)
Memory consolidation
Neuronal differentiation
Response to oxidative stress
Disease Associations
Alzheimer's Disease
Reduced p300/CBP activity in AD brains
p300/CBP is a target of [Aβ](/proteins/amyloid-beta) toxicity
Decreased H3 acetylation in AD hippocampus
Therapeutic potential of [HDAC](/entities/hdac-enzymes) inhibitors
Parkinson's Disease
p300/CBP involved in [α-synuclein](/proteins/alpha-synuclein) transcription regulation
Protects against MPTP-induced parkinsonism
Modulates dopaminergic neuron survival
Huntington's Disease
Mutant [huntingtin](/proteins/huntingtin-protein) disrupts p300/CBP function
Conditional knockouts: Show learning/memory deficits
Heterozygous mice: Display cognitive impairments
Transgenic models: p300 overexpression protects against Aβ
Research Directions
Developing brain-penetrant HDAC inhibitors
Understanding p300 isoform-specific functions
Targeting p300-CBP interactions for neurodegeneration
Epigenetic therapy approaches
Background
The study of Ep300 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.